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ABSTRACT
Objectives: The study has been carried to investigate the electro-oxidation mechanism and to develop selective and sensitive methods for the 
determination of a non-opioid analgesic drug ketorolac (KTL).
Methods: A simple method was used for the determination of KTL using a glassy carbon electrode by cyclic and differential pulse voltammetric 
techniques. The effect of various experimental parameters such as accumulation time, pH, scan rate, on the voltammetric responses of KTL was 
evaluated.
Results: In the optimized conditions, variation of peak current with respect to concentration was studied and the calibration curve of the peak current 
versus KTL concentration was drawn with a linear range of 10–350 μM and an excellent detection limit of 8.08×10−8 M. The method was successfully 
applied for the determination of KTL in pharmaceuticals and human urine samples.
Conclusions: From the results, it has been observed that the selected method is rapid, sensitive, and low cost.
Keywords: Ketorolac, Glassy carbon electrode, Calibration curve, Detection limit, Pharmaceutical analysis.
INTRODUCTION
In the past few decades, electrochemical techniques have been 
received considerable interest in the detection of small bio-molecules 
due to their high sensitivity, rapid response, simple operation, and low 
expense [1].
Ketorolac (KTL, as shown in Scheme 1) is a potent intravenous NSAID 
and a non-selective cyclo-oxygenase inhibitor which mediates pain, 
inflammation, and fever [2]. It has been evaluated and used for the 
treatment of moderate to severe pain including post-operative pain [3].
KTL crosses the placenta and is also excreted into breast milk in 
small quantities. The hydrophilicity and high protein binding of KTL 
prevent large concentrations of the drug from entering the breast milk. 
Administrations of KTL and other NSAIDs during the third trimester 
are contraindicated because they can cause premature closure of the 
ductus arteriosus.
A number of analytical methods have been investigated for the 
determination of KTL either alone or in its salt form or combination 
with other drugs, such as liquid chromatography-mass spectrometry 
(LC-MS/MS) [4], high-performance thin-layer chromatography [5], 
LC-MS [6], and high-performance liquid chromatography (HPLC) [7-11]. 
KTL has been determined in blood after a solid-phase extraction by 
gas chromatography-MS after derivatization using diazopropane [12]. 
Study in human serum has been performed by HPLC [13,14]. A flow 
injection analysis (FIA) method with spectrophotometric detection 
after derivatization with dichloronitrophenol in pharmaceutical 
formulations was published [15].
Most of the reported spectrophotometric methods based on derivative 
technique have shown poor selectivity, sensitivity, and required 
additional software’s. Although the FIA and gas chromatographic 
methods have shown high sensitivities, they are expensive, involving 
the use of complex procedures with several sample manipulations 
and take longer analysis time. Hence, the development of an effective 
and efficient method for the determination of KTL in pharmaceutical 
preparation and biological fluids is an important task. To the best of our 
knowledge, only a few electrochemical methods have been reported 
for the determination of KTL in literature. The current study describes 
the determination of KTL in tablets and spiked human urine samples 
at glassy carbon electrode (GCE). The proposed method showed many 
advantages such as low detection limit, fast response, easy to apply, 
and economical for routine analysis. We believe that the proposed 




All chemicals and reagents were of analytical grade and used as 
received. KTL was purchased from Sigma-Aldrich. 0.2 M phosphate 
buffer solutions (pH 3.0–11.2) were prepared using H3PO4, Na2HPO4, 
and NaH2PO4, and double-distilled water was used throughout the 
experiment.
Instrumentation
All the voltammetric measurements (cyclic voltammetry and 
differential pulse voltammetry [DPV]) were carried out on CHI1112C 
(Version 9.03) using a 10 mL capacity electrochemical cell with the 
conventional three-electrode system: A platinum wire as a counter 
electrode, an Ag/AgCl electrode as the reference, and the GCE as 
working electrode. Solutions of various pHs were used, adjusted with 
H3PO4, Na2HPO4, and NaH2PO4 (different supporting electrolytes were 
also tested, such as Britton-Robinson buffer and acetate buffer). The 
pH of the buffer solution was measured using Elico model EI120 pH 
meter. All experiments were carried out at an ambient temperature of 
25±0.1°C.
© 2019 The Authors. Published by Innovare Academic Sciences Pvt Ltd. This is an open access article under the CC BY license (http://creativecommons. 
org/licenses/by/4. 0/) DOI: http://dx.doi.org/10.22159/ajpcr.2019.v12i3.29914
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Area of the electrode
The area of the electrode was obtained by a cyclic voltammetric 
method using 1.0 mM K3Fe(CN)6 as a probe at different scan rates. For 
a reversible process, the following Randles–Sevcik formula [16] can be 
used to calculate the area of the electrode:
ipa = (2.69×10−5)n3/2AD01/2C0V1/2
Where ipa refers to the anodic peak current, n is the number of 
electrons transferred, A is the surface area of the electrode, DO is 
diffusion coefficient, υ is the scan rate, and CO is the concentration 
of K3Fe(CN)6. For 1.0 mM K3Fe(CN)6 in 0.1 M KCl electrolyte, n=1, 
DO=7.6×10−6 cm2/s [16], then from the slope of the plot of ipa versus υ1/2, 
the surface area of the electrode can be calculated. In our experiment, 
the slope was 14.15×10−6μA (Vs−1)−1/2 and the area of electrode was 
calculated to be 0.0212 cm2.
Analytical procedure
For good reproducible results, the working electrode was carefully 
polished with 1 μm, 0.3 μm, and 0.05 μm α-alumina on smooth polishing 
cloth and then washed in double-distilled water. The three electrode 
systems consisting of a GCE (3 mm diameter) as the working electrode, 
an Ag/AgCl (3 M KCl) reference electrode, and a platinum wire as the 
auxiliary (counter) electrodes were used. The experimental conditions 
for DPV were: Initial potential: 1.1 V, final potential: 1.4 V, sensitivity: 
1×10−6A/V, pulse amplitude: 50 mV, sample width: 20 ms, pulse period: 
500 ms, and scan rate: 50 mV/s.
Standard and pharmaceutical sample preparation
The commercially available tablets of KTL were weighed and powdered 
using pastel mortars. A portion of the powder equivalent to about 1.0 
mM was weighed accurately, transferred to a 100 mL calibrated flask and 
completed the volume with double distilled water. It was then sonicated 
for 15 min to effect complete dissolution and diluted to volume with 
water. Suitable amounts of this solution were taken and analyzed. The 
amount of KTL in the tablet was calculated using a calibration graph or 
regression equation.
To study the accuracy of the proposed method, and to check the interference 
from excipients used in the dosage forms, recovery experiments were 
carried out by the standard addition method. This study was performed 
by addition of known amounts of KTL to a known concentration of the 
tablets. The resulting mixture was analyzed as in pure KTL.
Determination of KTL in spiked human urine samples
Using the calibration curve method, the application of the method for 
the determination of KTL in human urine was also investigated. The 
urine sample was diluted 100 times with 0.2 M PBS (pH=3.8) to fit the 
calibration curve and reduce the matrix effect. No other pre-treatment 
process was performed.
ESULTS AND DISCUSSION
Cyclic voltammetric investigation of KTL
The voltammetric behavior of KTL was investigated using cyclic 
voltammetry. Fig. 1 shows typical cyclic voltammograms of 0.1 mM of 
KTL, in PBS of pH 3.8 at scan rate 50 mV/s recorded at GCE. This shows 
two oxidation peaks at 0.982 V and 1.355 V. On scanning in the negative 
direction; no reduction peak was observed, showing that the oxidation 
of KTL is an irreversible process in this potential range. The peak 
intensity and peak current of the second oxidation peak are maximum, 
hence, selected the same for the analytical purpose.
Effect of pH
The electrochemical responses of 0.1 mM KTL at GCE in phosphate 
buffer of different pH (3.0–11.2) were investigated, and the 
corresponding voltammograms are shown in Fig. 2a. It was noticed 
that the oxidation peak shifted toward negative potentials with 
an increase in pH indicating the role of protons in the oxidation 
process [17]. For pHs comprised between three and seven, two 
well-defined voltammetric peaks were observed. At pH above seven 
these two peaks were fused into only one peak. The evolution of both 
peak potential and peak current with pH, for both peaks, is shown 
in Fig. 2b and c. Furthermore, both peaks potential showed a linear 
dependence with the pH variation confirms the transfer of electrons 
and protons during the electrochemical process [18-20]. The equations 
relating to them can be represented as:
Ep = −0.003pH+1.369 (R²=0.974)
Ep = −0.003742pH+0.998251 (R²=0.985)
Effect of the time and potential of the accumulation
In the accumulation step, two important parameters are potential and 
time of accumulation, which can affect the sensitivity of determination 
via changing the amount of adsorbed KTL at the surface of modified 
electrode. Hence, influence of these parameters on the peak current 
was studied by the cyclic voltammetric method. It was found that by 
increasing the accumulation time, until 50 s, the peak current was 
increased; due to increasing the amount of the adsorbed analyte and 
it can be seen that after 50 s, the peak current stays nearly constant.
At the optimum value of accumulation time (50 s), the effect of 
accumulation potential was investigated form 0.2 to −0.2 V. The results 
showed that changing the potential of accumulation step from open 
circuit condition has no effect on the peak current. Therefore, 50 s 
of accumulation time in an open circuit condition was chosen for the 
accumulation step in all voltammetric determinations.
Effect of the potential scan rate
Cyclic voltammetric studies at different potential scan rates 
(25–400 mV/s) for 0.1 mM solution of KTL were performed on the 
surface of GCE in a PBS of pH 3.8 as shown in Fig. 3a. It was found 
that the peak current has a linear relationship with the square root of 
scan rate as it is shown in Fig. 3b. This linear relationship confirms the 
diffusion-controlled process [21] for the electro-oxidation of KTL at the 
electrode. Further, the plots of log Ipa versus log υ gave the slope of 0.39 
for peak 1 and 0.31 for peak 2(logIpa1=0.391log υ+1.296 R²=0.943; log 
Ipa2=0.317 log υ+0.749, R²=0.969) confirming the diffusion controlled 
electrode process [21,22].
Scheme 1: Chemical structure of ketorolac
Fig. 1: Cyclic voltammogram of 0.1 mM KTL at (a) bare glassy 
carbon electrode, (b) glassy carbon electrode + KTL; scan rate 
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As for an irreversible electrode process, according to Laviron [23], Epa is 

































Where α is the transfer coefficient, k0 the standard heterogeneous 
rate constant of the reaction, n the number of electrons transferred, 
υ the scan rate, and E0’ is the formal standard redox potential. Other 
symbols have their usual meaning. Thus, the value of αn can be easily 
calculated from the slope of Ep versus log υ plot. In this system, the 
slope is 0.054 and 0.030 for peak 1 and peak 2, respectively. Taking 
α=0.5 for irreversible electrode process, T=298 K, R=8.314 JK/mol, and 
F=96480 C/mol, the number of electrons (n) transferred in the electro-
oxidation of KTL was calculated to be 1.24~1.0 and 2.23~2.0 for first 
and second peak, respectively. The value of k0 can be determined from 
the intercept of the previous equations, if the value of E0’ is known. The 
value of E0’ in eqn. (1) can be obtained from the intercept of Ep versus 
υ curve by extrapolating to the vertical axis at υ=0 [24]. In our system, 
the intercept for Ep versus log υ plot was 1.065 and 1.368 for peak 1 and 
Fig. 3: (a) Cyclic voltammograms for the oxidation of KTL at different scan rates (1)–(16): 25 m v/s - 400 m v/s. (b) Dependence of 
oxidation peak current on the square root of scan rate
ba
Fig. 2: (a) Influence of pH on the shape of the anodic peak, pH: 3.0–11.2. (b) Variations of peak currents Ipa (μA) of KTL with pH. 
(c) Influence of pH on the peak potential Ep (V) of KTL. Other conditions as shown in Fig. 1
c
ba
Table 1: Characteristics of KTL calibration plot using differential 
pulse voltammetry at a glassy carbon electrode
Linearity range 10–350 μM
Slope of the calibration plot 340.0
Intercept 3.677
Correlation coefficient (r) 0.987
RSD of slope (%) 0.26
RSD of intercept (%) 1.33
Number of data points 12
LOD (M) 8.08×10−8
LOQ (M) 2.69×10−7
RSD: Relative standard deviation, LOD: Limit of detection, LOQ: Limit of 
quantitation
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peak 2, respectively, and E0’ were 0.992 and 1.326, respectively. From 
the above, calculated k0 values were 140.73/s and 269.63/s.
Electro-oxidation mechanism
Exact oxidation mechanism was not determined for KTL, but some 
conclusions about the electroactive group can be reached. Two pK 
values were reported for KTL, a pK value of 3.5 due to the carboxylic 
group [25] and another 6.2, due to protonation of the tertiary nitrogen 
in the pyrrole nucleus, from polarographic determination [26]. As the 
oxidation peaks were observed till pH 7.0 and after that the peaks 
were vanishes, it can be concluded that heterocyclic nitrogen is directly 
involved as the electro-oxidable group. Based on all the experimental 
results and the reported works [26-28] electro-oxidation mechanism 
for KTL in the acidic medium can be given as shown in Scheme 2.
Analytical determinations
Under the optimized experimental conditions, GCE was used for the 
determination of KTL by means of DPV. DPV is having better resolving 
power and higher sensitivity than CV. Fig. 4 shows the DPVs of KTL at 
different concentrations. The results showed that the peak current (I) has 
a linear relationship with the concentration of KTL in the range of 10.0–
350.0 μM with the following linear characteristics, which is shown in Fig. 
4 inset: Ipa(10−5A)=340.0 KTL+3.677(R2=0.987). In these measurements, 
a theoretical detection limit (S/N=3) of 8.08×10-8 M was obtained for KTL.
As mentioned in the introduction, only a few analytical methods have 
been reported for the determination of KTL in pharmaceutical or urine 
samples. Thus, Table 1 shows the analytical parameters obtained in this 
work and Table 2 shows the parameters obtained using other reported 
analytical techniques. It can be observed that the analytical parameters 
obtained, in terms of LOD, herein are better than those based in usual 
analytical methods [8,25,28-30]. Besides that, HPLC-MS and GC–MS 
methods require high consumption of organic solvent are time-
consuming for sample pre-treatment, on the other hand, our method 
requires minimal sample pre-treatment and the instrumentation is 
inexpensive.
Interference study
Under the optimized conditions, the influence of various common 
interferences in pharmaceutical samples for the determination of 
KTL was studied. 1000-fold Glucose, Gum Acacia, Sucrose, Citric acid, 
Dextrose, Lactose, Tartaric acid, and Starch had no obvious interference 
with the current response of KTL (signal change <10%). The results are 
as shown in Table 3.
Determination of KTL in pharmaceutical preparations
To demonstrate the electrocatalytic oxidation of KTL in pharmaceutical 
preparations, we examined this ability in DPV for determination of KTL 
concentration in tablet sample.
Fig. 4: Differential pulse voltammograms for increasing 
concentration of KTL at GCE: (a)-(l): 10 μM–350, inset: Plot of 
current against the concentration of KTL
Scheme 2: Probable electro-oxidation mechanism of KTL
Table 2: Comparison of detection limits for KTL to different classical methods
Method LOD References
RP-HPLC method 3.97×10−7 M (0.116 μg/mL) 8
LC and LC-MS 7.19×10−7 M (0.21 μg/mL) 28
Spectrophotometric method 1.18×10−7 M 25
Differential pulse polarographic determination 4.04×10−6 M 27
Zero-crossing derivative spectrophotometry 1.13×10−6 M (0.33 μg/mL) 29
Ratio spectra derivative spectrophotometry 2.23×10−6 M (0.65 μg/mL) 29
Ratio difference spectrophotometry 1.71×10−6 M (0.50 μg/mL) 29
HPLC-DAD 2.74×10−6 M (0.80 μg/mL) 29
Voltammetric method 8.08×10−8 M Present method
HPLC: High-performance liquid chromatography, LOD: Limit of detection, LC-MS: Liquid chromatography-mass spectrometry
Table 3: Influence of potential excipients on the voltammetric 
response of 1.0×10−6 M KTL






Only Ketorolac 1.280 0
Tartaric acid+KTL 1.271 −0.703
Citric acid+KTL 1.255 −1.95
Glucose+KTL 1.270 −0.78





Table 4: Analysis of KTL tablet by DPV and recovery studies
Ketorol (10 mg) DPV
Labeled claim (mg) 10.00








aAverage of three determinations. DPV: Differential pulse voltammetry, 
RSD: Relative standard deviation
203
Asian J Pharm Clin Res, Vol 12, Issue 3, 2019, 199-204
 Hanabaratti et al. 
The tablets were grounded to powder, dissolved in water and then 
further diluted so that KTL concentration falls in the range of calibration 
plot. DPV were then recorded under exactly identical conditions that 
were employed while recording differential-pulse voltammograms for 
plotting calibration plot. Based on the repeated DPV responses (n=3) of 
the diluted analytes and the samples that were spiked with a specified 
concentration of KTL and using the calibration plot measurements were 
made of KTL concentrations in the pharmaceutical preparations and the 
recovery rate of the spiked samples. The results are listed in Table 4.
Recovery study of KTL in a urine sample
The developed DPV method for the KTL determination was applied to 
urine samples. The recoveries from urine were measured by spiking 
drug-free urine with known amounts of KTL. A quantitative analysis 
can be carried out by adding the standard solution of KTL into the 
detection system of urine samples. The calibration graph was used for 
the determination of spiked KTL in urine samples. The detection results 
of four urine samples obtained with recovery percentage and RSD are 
listed in Table 5.
Repeatability and reproducibility of the electrode
The precision of the method was evaluated by repeating five experiments 
on the same day and in the same standard condition (repeatability) and 
over 2 days from the different standard solutions (reproducibility). 
For these studies, 1.0×10−6 M KTL standard solution was used. The 
corresponding RSD of the peak current of 2.49% and 2.44% confirms 
that the electrode has good repeatability and reproducibility.
CONCLUSIONS
In this study, the voltammetric determination of KTL is carried out by 
GCE in a phosphate buffer solution of pH 3.8. pH effects showed the role 
of proton transfer in the electrochemical process. Effect of potential 
scan rate was examined, and the results show that the electrochemical 
process is diffusion controlled. The number of electrons transferred 
during the process was calculated. Under the optimum condition, KTL 
shows a linear response in the concentration range from 10 to 350 μM 
and a detection limit of 8.08×10−8 M, besides presenting good intra- and 
inter-day repeatability. The method has been successfully applied to the 
determination of KTL in pharmaceutical samples and recovery study in 
urine sample successively.
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